Literature DB >> 19527186

Treatment strategies for peripheral artery disease.

Andrew B McCann1, Michael R Jaff.   

Abstract

Peripheral arterial disease is an underecognized manifestation of systemic atherosclerosis associated with high rates of cardiovascular morbidity and mortality. The rationale of therapy is to reduce cardiovascular risk, improve symptoms of intermittent claudication, and prevent the development of critical limb ischemia and amputation. Exercise therapy and several pharmacologic agents have been shown to improve walking distance in patients with intermittent claudication. Patients with lifestyle-interfering symptoms despite exercise, or those who progress to critical limb ischemia, frequently undergo revascularization. Endovascular techniques are commonly used in these patients. Combined pharmacological and endovascular strategies will play an increasing role in management of these patients in the future.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19527186     DOI: 10.1517/14656560902988502

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  5 in total

1.  Critical limb ischemia.

Authors:  Paolo Gresele; Chiara Busti; Tiziana Fierro
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

2.  Differential effect of zoledronic acid on human vascular smooth muscle cells.

Authors:  Hassan Albadawi; Mounir J Haurani; Rahmi Oklu; Jordan P Trubiano; Peter J Laub; Hyung-Jin Yoo; Michael T Watkins
Journal:  J Surg Res       Date:  2012-11-08       Impact factor: 2.192

Review 3.  S100A1: a multifaceted therapeutic target in cardiovascular disease.

Authors:  David Rohde; Julia Ritterhoff; Mirko Voelkers; Hugo A Katus; Thomas G Parker; Patrick Most
Journal:  J Cardiovasc Transl Res       Date:  2010-07-20       Impact factor: 4.132

Review 4.  Is gene therapy for limb ischemia a reality?

Authors:  Sang Won Han; Carlos Alberto Vergani; Paulo Eduardo Ocke Reis
Journal:  J Vasc Bras       Date:  2020-05-29

Review 5.  An Overview of Meta-Analyses of Danhong Injection for Unstable Angina.

Authors:  Xiaoxia Zhang; Hui Wang; Yanxu Chang; Yuefei Wang; Xiang Lei; Shufei Fu; Junhua Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-11       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.